NLRP3 inflammasome pathway protein (NLRP3 (for main sensor protein), ASC (adaptor), Caspase-1 (effector))

The **NLRP3 inflammasome pathway protein** refers to the core molecular components of the NLRP3 inflammasome, a cytosolic multiprotein complex that senses diverse pathogen-associated or danger-associated molecular patterns (PAMPs, DAMPs) and regulates innate immune responses through the maturation and secretion of pro-inflammatory cytokines such as interleukin-1β (IL-1β) and interleukin-18 (IL-18). The canonical NLRP3 inflammasome is composed of the sensor protein NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3), the adaptor ASC (apoptosis-associated speck-like protein containing a CARD), and the effector protease Caspase-1. Upon activation, NLRP3 oligomerizes and recruits ASC, which in turn recruits and activates pro-caspase-1, leading to cytokine processing and induction of lytic pyroptotic cell death. Aberrant activation of the NLRP3 inflammasome pathway is implicated in a wide range of inflammatory, neurodegenerative, cardiovascular, metabolic, and auto-inflammatory diseases, making its components attractive targets for therapeutic intervention[1][2][3][4][5][7]. Note: “NLRP3 inflammasome pathway proteins” is a collective term for multiple proteins forming a pathway and not a single molecular target. For structured data on an individual protein (e.g., NLRP3 or ASC), separate entries should be created.

Other names

NLRP3 inflammasomeNALP3 inflammasomeCryopyrin inflammasomeNod-like receptor protein 3 inflammasomeNLRP3 complex

Direct inhibition of NLRP3 ATPase activity (e.g., MCC950, CY-09, OLT1177); Inhibition of IL-1β or IL-18 signaling (e.g., Anakinra, Canakinumab, Rilonacept); Blocking ASC oligomerization/speck formation; Suppression of inflammasome priming or assembly